- Home
- BDN vs CMPX Comparison
BDN vs CMPX Comparison
Compare BDN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDN
- CMPX
- Stock Information
- Founded
- BDN 1986
- CMPX 2014
- Country
- BDN United States
- CMPX United States
- Employees
- BDN N/A
- CMPX N/A
- Industry
- BDN Real Estate Investment Trusts
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- BDN Real Estate
- CMPX Health Care
- Exchange
- BDN Nasdaq
- CMPX Nasdaq
- Market Cap
- BDN 693.1M
- CMPX 730.9M
- IPO Year
- BDN N/A
- CMPX N/A
- Fundamental
- Price
- BDN $3.68
- CMPX $4.22
- Analyst Decision
- BDN Hold
- CMPX Strong Buy
- Analyst Count
- BDN 2
- CMPX 7
- Target Price
- BDN $4.50
- CMPX $14.71
- AVG Volume (30 Days)
- BDN 2.5M
- CMPX 1.7M
- Earning Date
- BDN 10-22-2025
- CMPX 11-11-2025
- Dividend Yield
- BDN 8.67%
- CMPX N/A
- EPS Growth
- BDN N/A
- CMPX N/A
- EPS
- BDN N/A
- CMPX N/A
- Revenue
- BDN $306,596,000.00
- CMPX N/A
- Revenue This Year
- BDN $54.50
- CMPX N/A
- Revenue Next Year
- BDN $3.25
- CMPX N/A
- P/E Ratio
- BDN N/A
- CMPX N/A
- Revenue Growth
- BDN N/A
- CMPX N/A
- 52 Week Low
- BDN $3.41
- CMPX $1.27
- 52 Week High
- BDN $6.54
- CMPX $4.86
- Technical
- Relative Strength Index (RSI)
- BDN 28.32
- CMPX 58.74
- Support Level
- BDN $3.64
- CMPX $3.31
- Resistance Level
- BDN $3.84
- CMPX $4.86
- Average True Range (ATR)
- BDN 0.11
- CMPX 0.29
- MACD
- BDN -0.04
- CMPX 0.06
- Stochastic Oscillator
- BDN 14.05
- CMPX 58.36
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.